Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Cash from Investing Activities came in at $4.7 million in Q3 2025, up 332.9% year-on-year from $1.1 million in Q3 2024, and up 1576.03% on a QoQ basis from -$317000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Cash from Investing Activities data on file, last reported at $4.7 million in Q3 2025.
- On a quarterly basis, Cash from Investing Activities rose 332.9% year-over-year to $4.7 million in Q3 2025; TTM through Sep 2025 was $2.7 million, a 148.43% increase from a year earlier, with the FY2024 full-year figure at -$3.7 million, up 84.95% from the prior year.
- Cash from Investing Activities for Q3 2025 stood at $4.7 million, up from -$317000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for XTNT reached as high as $4.7 million in Q3 2025 and fell as low as -$17.4 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$1.5 million across 5 years, with a median of -$483000.0 in 2021.
- Across the five-year window, Cash from Investing Activities plunged 4355.5% in 2023 and soared 332.9% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$595000.0 in 2021, then climbed by 29.08% to -$422000.0 in 2022, then tumbled by 448.1% to -$2.3 million in 2023, then jumped by 75.49% to -$567000.0 in 2024, then jumped by 925.22% to $4.7 million in 2025.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $4.7 million in Q3 2025, -$317000.0 in Q2 2025, and -$1.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.68 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | -317,000.00 |
| Jun 30, 2025 | -317,000.00 |
| Mar 31, 2025 | -1.14 Mn |
| Mar 31, 2025 | -1.14 Mn |
| Dec 31, 2024 | -567,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -480,000.00 |
| Jun 30, 2024 | -480,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Dec 31, 2023 | -2.31 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Jun 30, 2023 | -394,000.00 |
| Jun 30, 2023 | -394,000.00 |